{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:57:16Z","timestamp":1740135436324,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873837"],"award-info":[{"award-number":["81873837"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Intrahepatic cholestasis of pregnancy (ICP) is a common gestational complication characterized by pruritus and elevated bile acids, usually occurring in the third trimester when the serum estrogen and progesterone levels are highest. Hyperandrogenism during pregnancy is a pathological state that is mostly induced by polycystic ovary syndrome (PCOS) but rarely by concomitant androgen-secreting ovarian tumours. To date, no correlation has been drawn between ICP and hyperandrogenism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here, we present a rare case of early-onset severe ICP in a PCOS patient conceived via in vitro fertilization-embryo transfer, with worsening hirsutism and acne due to high levels of testosterone and dehydroepiandrosterone sulphate, both of which were produced by a fast-growing ovarian Sertoli\u2013Leydig cell tumour. Her serum estradiol was also very high, which was speculated to be converted from the circulating androgens by the placenta. She had preterm premature rupture of membranes and delivered at 30 weeks, followed by a rapid remission of ICP as her serum estradiol dropped. However, the excessive androgens did not retreat until the large ovarian tumour was surgically removed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This unusual case highlights the concurrence of original hyperandrogenism and subsequent hyperestrogenism during pregnancy and the resultant confounding manifestations. Obstetricians should be aware of the potential association between androgen excess and ICP via placental aromatization.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-022-05159-z","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T11:16:38Z","timestamp":1667387798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Severe intrahepatic cholestasis of pregnancy due to a Sertoli-Leydig cell tumour in a woman with polycystic ovary syndrome: a case report"],"prefix":"10.1186","volume":"22","author":[{"given":"Feng","family":"Yun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5957-1137","authenticated-orcid":false,"given":"Fangfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"5159_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.mam.2017.05.003","volume":"56","author":"S McIlvride","year":"2017","unstructured":"McIlvride S, Dixon PH, Williamson C. Bile acids and gestation. Mol Aspects Med. 2017;56:90\u2013100.","journal-title":"Mol Aspects Med"},{"issue":"4","key":"5159_CR2","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/hep.26617","volume":"59","author":"V Geenes","year":"2014","unstructured":"Geenes V, Chappell LC, Seed PT, Steer PJ, Knight M, Williamson C. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology (Baltimore MD). 2014;59(4):1482\u201391.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"10174","key":"5159_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","volume":"393","author":"C Ovadia","year":"2019","unstructured":"Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet (London England). 2019;393(10174):899\u2013909.","journal-title":"Lancet (London England)"},{"issue":"2","key":"5159_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.33549\/physiolres.932078","volume":"60","author":"N Ka\u0148ov\u00e1","year":"2011","unstructured":"Ka\u0148ov\u00e1 N, Bi\u010d\u00edkov\u00e1 M. Hyperandrogenic states in pregnancy. Physiol Res. 2011;60(2):243\u201352.","journal-title":"Physiol Res"},{"issue":"56","key":"5159_CR5","doi-asserted-by":"publisher","first-page":"96351","DOI":"10.18632\/oncotarget.19180","volume":"8","author":"T Ding","year":"2017","unstructured":"Ding T, Hardiman PJ, Petersen I, Wang FF, Qu F, Baio G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget. 2017;8(56):96351\u20138.","journal-title":"Oncotarget"},{"issue":"3","key":"5159_CR6","first-page":"168","volume":"100","author":"E Matheson","year":"2019","unstructured":"Matheson E, Bain J. Hirsutism in Women. Am Family Phys. 2019;100(3):168\u201375.","journal-title":"Am Family Phys"},{"key":"5159_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000494906","volume":"53","author":"D Macut","year":"2019","unstructured":"Macut D, Ili\u0107 D, Mitrovi\u0107 Jovanovi\u0107 A, Bjeki\u0107-Macut J. Androgen-Secreting Ovarian Tumors. Front Horm Res. 2019;53:100\u20137.","journal-title":"Front Horm Res"},{"issue":"5","key":"5159_CR8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/01443615.2017.1291590","volume":"37","author":"LM Melero Cort\u00e9s","year":"2017","unstructured":"Melero Cort\u00e9s LM, Mart\u00ednez Maestre M, Vieites P\u00e9rez-Quintela MB, Gambadauro P. Ovarian Sertoli-Leydig cell tumours: How typical is their typical presentation? J Obstet Gynaecol. 2017;37(5):655\u20139.","journal-title":"J Obstet Gynaecol"},{"issue":"4","key":"5159_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1582-4934.2003.tb00249.x","volume":"7","author":"A Gheorghisan-Galateanu","year":"2003","unstructured":"Gheorghisan-Galateanu A, Fica S, Terzea DC, Caragheorgheopol A, Horhoianu V. Sertoli-Leydig cell tumor - a rare androgen secreting ovarian tumor in postmenopausal women. Case report and review of literature. J Cell Mol Med. 2003;7(4):461\u201371.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"5159_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3109\/09513590.2012.738723","volume":"29","author":"H Xiao","year":"2013","unstructured":"Xiao H, Li B, Zuo J, Feng X, Li X, Zhang R, et al. Ovarian Sertoli-Leydig cell tumor: a report of seven cases and a review of the literature. Gynecol Endocrinol. 2013;29(3):192\u20135.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"5159_CR11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ygyno.2012.07.114","volume":"127","author":"T Gui","year":"2012","unstructured":"Gui T, Cao D, Shen K, Yang J, Zhang Y, Yu Q, et al. A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors. Gynecol Oncol. 2012;127(2):384\u20139.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"5159_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4158\/EP.15.2.149","volume":"15","author":"JD Herrera","year":"2009","unstructured":"Herrera JD, Davidson JA, Mestman JH. Hyperandrogenism due to a testosterone-secreting Sertoli-Leydig cell tumor associated with a dehydroepiandrosterone sulfate-secreting adrenal adenoma in a postmenopausal woman: case presentation and review of literature. Endocr Pract. 2009;15(2):149\u201352.","journal-title":"Endocr Pract"},{"issue":"1","key":"5159_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.yexmp.2006.08.001","volume":"82","author":"X Sun","year":"2007","unstructured":"Sun X, Hawkins H, Castro CY, Eltorky MA. Immunohistochemical and ultrastructural analysis of a poorly differentiated pediatric age Sertoli-Leydig cell tumor. Exp Mol Pathol. 2007;82(1):63\u20137.","journal-title":"Exp Mol Pathol"},{"issue":"5","key":"5159_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/09513590.2018.1564742","volume":"35","author":"N Noyola-Mart\u00ednez","year":"2019","unstructured":"Noyola-Mart\u00ednez N, Halhali A, Barrera D. Steroid hormones and pregnancy. Gynecol Endocrinol. 2019;35(5):376\u201384.","journal-title":"Gynecol Endocrinol"},{"key":"5159_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.fct.2019.03.043","volume":"128","author":"Y Wang","year":"2019","unstructured":"Wang Y, Pan P, Li X, Zhu Q, Huang T, Ge RS. Food components and environmental chemicals of inhibiting human placental aromatase. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association. 2019;128:46\u201353.","journal-title":"Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association"},{"issue":"3","key":"5159_CR16","first-page":"372","volume":"95","author":"KK Leslie","year":"2000","unstructured":"Leslie KK, Reznikov L, Simon FR, Fennessey PV, Reyes H, Ribalta J. Estrogens in intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2000;95(3):372\u20136.","journal-title":"Obstet Gynecol"},{"issue":"17","key":"5159_CR17","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3748\/wjg.15.2049","volume":"15","author":"V Geenes","year":"2009","unstructured":"Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2009;15(17):2049\u201366.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"5159_CR18","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1210\/jc.2018-00889","volume":"103","author":"D Glintborg","year":"2018","unstructured":"Glintborg D, Jensen RC, Bentsen K, Schmedes AV, Brandslund I, Kyhl HB, et al. Testosterone Levels in Third Trimester in Polycystic Ovary Syndrome: Odense Child Cohort. J Clin Endocrinol Metab. 2018;103(10):3819\u201327.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"5159_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1631\/jzus.B1700074","volume":"19","author":"FF Wang","year":"2018","unstructured":"Wang FF, Pan JX, Wu Y, Zhu YH, Hardiman PJ, Qu F. American, European, and Chinese practice guidelines or consensuses of polycystic ovary syndrome: a comparative analysis. J Zhejiang Univ Sci B. 2018;19(5):354\u201363.","journal-title":"J Zhejiang Univ Sci B"},{"key":"5159_CR20","unstructured":"Puziga\u0107a S, Prelevi\u0107 G, Svetenovi\u0107 Z, Djurici\u0107 S, Kokan D, Radivojevi\u0107 U. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation]. Srpski arhiv za celokupno lekarstvo. 2001;129Suppl 1:51\u20135."},{"issue":"2","key":"5159_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s12020-013-0066-0","volume":"46","author":"RM Paragliola","year":"2014","unstructured":"Paragliola RM, Torino F, Senes P, Castellino L, Salutari V, Pontecorvi A, et al. \u201cOccult\u201d ovarian Leydig cell tumor: when laboratory tells more than imaging. Endocrine. 2014;46(2):351\u20134.","journal-title":"Endocrine"},{"issue":"3","key":"5159_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1471-0528.1999.tb08245.x","volume":"106","author":"M Widschwendter","year":"1999","unstructured":"Widschwendter M, Meduri G, Loosfelt H, Schr\u00f6cksnadel H, Hittmair A, M\u00fcller-Holzner E, et al. Fulminant recurrence of a Sertoli-Leydig cell tumour during pregnancy. Br J Obstet Gynaecol. 1999;106(3):284\u20135.","journal-title":"Br J Obstet Gynaecol"},{"issue":"42","key":"5159_CR23","doi-asserted-by":"publisher","first-page":"e12865","DOI":"10.1097\/MD.0000000000012865","volume":"97","author":"Q Xu","year":"2018","unstructured":"Xu Q, Zou Y, Zhang XF. Sertoli-Leydig cell tumors of ovary: A case series. Medicine. 2018;97(42):e12865.","journal-title":"Medicine"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05159-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-05159-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05159-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T11:18:58Z","timestamp":1667387938000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-05159-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5159"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-05159-z","relation":{},"ISSN":["1471-2393"],"issn-type":[{"type":"electronic","value":"1471-2393"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"assertion":[{"value":"19 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Women\u2019s Hospital, School of Medicine, Zhejiang University (IRB-20220063-R). The patient described in this case report provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"807"}}